Why the study?
Can atypical T-wave evolution on ECG differentiate postinfarction pericarditis from other causes of postinfarction chest pain, and does lytic therapy affect its incidence?
Can atypical T-wave evolution on ECG differentiate postinfarction pericarditis from other causes of postinfarction chest pain, and does lytic therapy affect its incidence?
Atypical T-wave evolution on ECG can help differentiate postinfarction pericarditis from angina and reinfarction, and lytic therapy reduces the incidence of postinfarction pericarditis.
Answers are grounded in this paper and cite their sources.
Lytic therapy was associated with lower postinfarction pericarditis rates; leaves open causal benefit and need for randomized confirmation.
Recently two types of atypical T-wave evolution were recognized as electrocardiographic (ECG) markers of regional postinfarction pericarditis. The sensitivity and specificity of these changes for this condition were 100 and 77%, respectively. The major purpose of this investigation is to show how these ECG changes can be used to differentiate among postinfarction pericarditis, postinfarction angina, and reinfarction. Even appropriately constructed serial monitor lead ECGs can be used to make this distinction. The ease of correctly distinguishing among the three causes of postinfarction chest pain utilizing a carefully elicited history and ECG criteria is discussed. In addition, a secondary objective was to assess the effect of lytic therapy on the incidence of postinfarction pericarditis. Among the 200 patients in this study, lytic therapy halved the incidence of postinfarction pericarditis, which is in accord with the larger Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) study.
No takes yet. Share an insight, caveat, or question.
Oliva et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: